Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343083
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2006-06-20
Brief Title:
Evaluation of Cetuximab ERBITUX and Concurrent Carboplatin Paclitaxel Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck GCC 0442
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
HP-00042712
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
Department of Radiation Oncology
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland Baltimore
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |